Relmada Therapeutics (RLMD) Change in Inventory (2012 - 2013)

Relmada Therapeutics (RLMD) reported Change in Inventory of -$1565.0 for Q4 2013, down 184.59% year-over-year from $1850.0 in Q4 2012, and down 95.62% on a QoQ basis from -$800.0 in Q3 2013.

Relmada Therapeutics (RLMD) has 2 years of Change in Inventory data on file, last reported at -$1565.0 in Q4 2013.

  • Quarterly Change in Inventory fell 184.59% year-over-year to -$1565.0 in Q4 2013, while the trailing twelve-month figure through Nov 2013 was -$179.0 (changed N/A YoY) and the FY2013 annual result came in at $3236.0, up 559.06% from the prior year.
  • Change in Inventory declined to -$1565.0 in Q4 2013 per RLMD's latest filing, from -$800.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1865.0 in Q1 2013 and bottomed at -$1565.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 665.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 97.70 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.32 Mn
10 Relmada Therapeutics 595.35 Mn 595.35 Mn - -

Historic Data

Download Data 🔒
DateValue
Nov 30, 2013 -1,565.00
Nov 30, 2013 -1,565.00
Aug 31, 2013 -800.00
Aug 31, 2013 -800.00
May 31, 2013 321.00
May 31, 2013 321.00
Feb 28, 2013 1,865.00
Feb 28, 2013 1,865.00
Nov 30, 2012 1,850.00
Nov 30, 2012 1,850.00
Aug 31, 2012 1,348.00
Aug 31, 2012 1,348.00
May 31, 2012 678.00
May 31, 2012 678.00